论文信息 - Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma - 字舞流文

Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma

J. Larkin | M. Atkins | A. Poprach | D. Cho | G. Bjarnason | F. Donskov | D. McDermott | Jae-Lyun Lee | R. Perini | S. Tykodi | P. Geertsen | T. Alonso-Gordoa | R. Silverman | N. V. Jensen | M. C. Climent Duran | R. Gafanov | C. Schloss | M. Kochenderfer | J. Malik | C. DiSimone | M. A. C. Climent Duran | M. A. Climent Duran